EVOK Market Cap History
Below is a table of the EVOK market cap history going back to 9/25/2013:

Date EVOK Market Cap
9/25/201367.88M
10/31/201368.71M
3/20/201463.07M
5/2/201453.86M
8/1/201441.48M
10/31/201440.95M
2/23/201533.39M
4/30/201538.68M
7/31/201533.15M
10/31/201526.45M
2/29/201624.70M
4/30/201634.47M
8/9/201627.66M
11/4/201619.64M
3/10/201748.01M
5/5/201743.09M
8/4/201735.39M
11/3/201743.31M
2/28/201830.21M
5/8/201843.78M
8/3/201846.98M
10/31/201842.52M
2/28/201953.68M
4/30/201916.75M
7/31/201923.49M
10/31/201921.20M
2/29/202030.05M
5/7/202033.35M
7/31/202095.98M

Also see: EVOK Shares Outstanding History
and EVOK YTD Return
EVOK Historical Market Cap:
+5.19% CAGR
EVOK Historical Market Cap: +5.19% CAGR

Mouse over chart for data details
9/25/2013 ...7/31/2020
Evoke Pharma is a pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. Co. is developing Gimoti, an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Diabetic gastroparesis is a GI disorder is characterized by slow or delayed gastric emptying and evidence of gastric retention in the absence of mechanical obstruction and can cause various serious digestive system symptoms and other complications. Metoclopramide tablets and injection are the products approved in the U.S. to treat the symptoms associated with diabetic gastroparesis. We show 29 historical shares outstanding datapoints in our EVOK shares outstanding history coverage, used to compute EVOK market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EVOK market cap history over the course of time is important for investors interested in comparing EVOK's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EVOK versus a peer is one thing; comparing EVOK market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EVOK can fluctuate over the course of history. With this page we aim to empower investors researching EVOK by allowing them to research the EVOK market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for EVOK:
EVOK SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Evoke Pharma (EVOK) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

EW Market Cap History
EXAS Market Cap History
EXEL Market Cap History
EYE Market Cap History
EYEG Market Cap History
EYES Market Cap History
FATE Market Cap History
FCRE Market Cap History
FCSC Market Cap History
FGEN Market Cap History
More Healthcare companies »

 

EVOK Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.